December 5, 2013

Among diabetes sufferers and those with a diabetic in their household, the critical role of the physician in condition management is most visible, according to a recent online survey of more than 500 AccentHealth viewers. Eight-in-10 indicate their doctor is very or somewhat involved in their own or their household member's diabetes management; half report their doctor is their primary source for condition info — 43% more than those using the second-most common source, health-related web sites.

December 5, 2013

Making regular doctor appointments is the activity done most often by respondents (78%) to live a healthy life, at least 10 percentage points higher than diet and exercise, according to a recent online survey of more than 500 AccentHealth viewers with diabetes or a family history of diabetes. As many as 70% limit alcohol consumption, and 68% monitor their diet.

September 19, 2014

The Food and Drug Administration on Thursday approved Trulicity (dulaglutide), a once-a-week injection to improve blood-sugar levels in adults with Type 2 diabetes. 

September 16, 2014

In this special diabetes report, DSN covers the latest innovation in the diabetes sector from wearable technology to prescription drugs to devices to pharmacist care for diabetic patients.

September 15, 2014

Community pharmacists can dramatically help their patients stick to their prescription regimens, according to a new study led by researchers at the University of Pittsburgh School of Pharmacy. 

September 15, 2014

Among those with diabetes, patient-focused, collaborative care that includes pharmacists can positively impact health outcomes, particularly in underserved or uninsured populations.

September 15, 2014

Close to half (40%) of the U.S. adult population — roughly 126 million — is expected to develop Type 2 diabetes at some point during their lifetime, according to a study published in The Lancet Diabetes and Endocrinology in August.

September 15, 2014

Thanks to the Centers for Medicare and Medicaid Services’ Five-Star Quality Rating System, the diabetes community stands to play a significant role in how pharmacies think about their patients and their medication adherence programs. 

September 15, 2014

Sales of the popular Type 2 diabetes drug metformin may get a boost if physicians begin prescribing the medicine as a prophylactic in people who don’t have diabetes. A recent study published in the diabetes journal Diabetes, Obesity and Metabolism and conducted by scientists from Cardiff University found that patients treated with metformin could live longer than people without diabetes.

September 15, 2014

Dick Tracy has nothing on the wearable gadgets under development to help people better police their diabetes. Wearable technologies in its totality — which include Google Glass and the Apple Watch — are part of a booming market that’s expected to swell to $20 billion by 2015 and is further expected to grow at a compound annual growth rate of nearly 40% over the next six years.

September 9, 2014

AstraZeneca's once-weekly Bydureon (exenatide extended-release for injectable suspension) pen now is available in pharmacies across the United States, the company announced.

September 3, 2014

Abbott on Wednesday announced that it has received CE Mark (Conformite Europeenne) for its FreeStyle Libre Flash Glucose Monitoring System, a revolutionary new glucose-sensing technology for people with diabetes. 

August 27, 2014

"The diabetic is a critically important patient for pharmacies to serve. Yet, with increased Medicare audits, stringent compliance requirements and reduced reimbursements, is servicing these patients really worth it?" writes Kevin Dore, a director at Emdeon, in his latest blog.

August 26, 2014

Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Co. announced that Jardiance (empagliflozin) tablets are now available by prescription in pharmacies across the United States.

August 25, 2014

Nipro Diagnostics announced that the Food and Drug Administration approved its True Metrix self-monitoring blood-glucose system, as well as the True Metrix Pro professional monitoring blood-glucose system.

August 19, 2014

The Food and Drug Administration has granted tentative approval for Basaglar (insulin glargine injection), which is used to improve glycemic control in adults with Type 2 diabetes and in combination with mealtime insulin in adults and pediatric patients with Type 1 diabetes.

August 13, 2014

This year, thousands of people in communities across the country are expected to join the millions in the fight to stop diabetes by participating in the American Diabetes Association's Step Out: Walk to Stop Diabetes fundraising event.

August 11, 2014

Janssen Pharmaceuticals received approval from the Food and Drug Administration for Invokamet, a fixed-dose therapy that combines canagliflozin and metformin hydrochloride in a single tablet.

August 1, 2014

The Food and Drug Administration announced approval for Boehringer Ingelheim's Jardiance tablets.

July 30, 2014

GSK announced that Tanzeum (albiglutide), a once-weekly, prescription injectable treatment for Type 2 diabetes in adults, is now available in pharmacies throughout the United States.

July 16, 2014

HelpAround on Wednesday launched a mobile platform for people with diabetes — and their friends, family and caregivers — that reveals fellow ‘diabetes helpers’ from the crowd, helping people resolve sudden health crises, such as getting caught without essential over-the-counter blood glucose test strips.

July 7, 2014

The American Diabetes Association on Monday announced its collaboration with Walgreens, a national strategic partner of the association, and the Balance Rewards program to help further the movement to Stop Diabetes.

July 2, 2014

Larry Hausner, CEO of the American Diabetes Association, on Tuesday announced that he will step down as CEO, effective July 31, 2014, to pursue new opportunities in his native New York metro area.

June 30, 2014

Afrezza, an inhaled insulin powder meant to treat diabetes patients, was approved Friday by the Food and Drug Administration.